Variable | Total (n = 94) | Arterial thromboembolic event | Major bleeding event | Death | |||
---|---|---|---|---|---|---|---|
No (n = 87) | Yes (n = 7) | No (n = 76) | Yes (n = 18) | No (n = 67) | Yes (n = 27) | ||
LVEF, median (IQR), % (n = 94) | 55 (45–61) | 56 (45–62) | 51 (33–57) | 57 (49–62) | 47 (43–57) | 57 (49–61) | 51 (30–61)c |
LV systolic dysfunction (LVEF ≤ 45%), no. (%) (n = 94) | 27 (29) | 24 (28) | 3 (43) | 18 (23) | 9 (50)b | 16 (24) | 11 (41) |
LV systolic severe dysfunction (LVEF ≤ 30%), no. (%) (n = 94) | 9 (10) | 7 (8) | 2 (29) | 9 (12) | 0 | 2 (3) | 7 (26)c |
RV dilatation, no. (%) (n = 90)d | 27 (28) | 25 (30) | 2 (29) | 22 (30) | 5 (29) | 21 (33) | 6 (23) |
Paradoxical septum, no. (%) (n = 94) | 5 (5) | 4 (5) | 1 (14) | 5 (5) | 0 | 3 (4) | 2 (7) |
Significant left-sided valve disease, no. (%) (n = 94)e | 4 (4) | 2 (2) | 2 (29)a | 1 (1) | 3 (17)b | 2 (3) | 2 (7) |
LA area, median (IQR), cm2 (n = 70) | 20 (16–24) | 20 (16–23) | 25 (18–28) | 20 (16–23) | 21 (18–24) | 21 (16–25) | 18 (15–22) |
LA/LAA thrombus, no. (%) (n = 94) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LAA dysfunction, no. (%) (n = 88)f | 17 (19) | 16 (20) | 1 (14) | 12 (17) | 5 (28) | 12 (19) | 5 (19) |
LA/LAA dense SEC (n = 94) | 7 (7) | 6 (7) | 1 (14) | 6 (8) | 1 (6) | 5 (7) | 2 (7) |
LAA low velocity (n = 88)g | 11 (12) | 11 (14) | 0 | 7 (10) | 4 (22) | 7 (11) | 4 (15) |
LAA emptying velocity, median (IQR), cm/s (n = 89) | 66 (41–85) | 67 (41–83) | 63 (41–90) | 66 (43–81) | 65 (33–91) | 61 (44–85) | 70 (39–81) |
LAA filling velocity, median (IQR), cm/s (n = 88) | 60 (46–71) | 59 (45–71) | 65 (50–68) | 62 (46–72) | 56 (45–61) | 58 (47–72) | 62 (44–68) |
LAA large area (> 5 cm2), no. (%) (n = 87) | 13 (15) | 10 (12) | 3 (43) | 10 (14) | 3 (18) | 7 (11) | 6 (24) |
LAA area, median (IQR), cm2 (n = 87) | 3.2 (2.4–4.3) | 3.2 (2.4–4.1) | 4.9 (3.0–5.3) | 3.2 (2.4–4.3) | 3.4 (2.3–4.5) | 3.4 (2.3–4.2) | 3.1 (2.4–4.5) |
Severe aortic atheroma, no. (%) (n = 91) | 22 (24) | 21 (25) | 1 (14) | 18 (24) | 4 (23) | 18 (27) | 4 (16) |